Table III.
A, Training set | ||||
---|---|---|---|---|
Overall survival | ||||
Patients | Multivariate analysis | |||
Factor | No. | % | HR (95% CI) | P-value |
All training set patients | 113 | 100 | ||
Differentiation | 0.446 | |||
Well + moderately | 59 | 52.2 | 1.00 | |
Poorly | 54 | 47.8 | 1.17 (0. 61 to 2.26) | |
Lauren classification | 0.001 | |||
Intestinal | 70 | 61.9 | 1.00 | |
Diffuse | 43 | 38.1 | 2.81 (1.56 to 5.09) | |
TNM stage | <0.001 | |||
I+II | 52 | 46.0 | 1.00 | |
III | 61 | 54.0 | 4.93 (2.32 to 10.49) | |
TRIM29 expression | <0.001 | |||
Low | 47 | 41.6 | 1.00 | |
High | 66 | 58.4 | 5.68 (2.58 to 12.51) | |
B, Validation set | ||||
Overall survival | ||||
Patients | Multivariate analysis | |||
Factor | No. | % | HR (95% CI) | P-value |
All validation set patients | 130 | 100 | ||
Differentiation | 0.264 | |||
Well + moderately | 65 | 50.0 | 1.00 | |
Poorly | 65 | 50.0 | 1.18 (0.88 to 1.60) | |
Lauren classification | 0.047 | |||
Intestinal | 61 | 46.9 | 1.00 | |
Diffuse | 69 | 53.1 | 1.73 (1.46 to 3.19) | |
TNM stage | <0.001 | |||
I+II | 45 | 34.6 | 1.00 | |
III | 85 | 65.4 | 8.28 (3.16 to 21.70) | |
TRIM29 expression | 0.003 | |||
Low | 61 | 46.9 | 1.00 | |
High | 69 | 53.1 | 3.32 (1.50 to 7.41) |
CI, confidence interval; HR, hazard ratio; TNM, tumor-node-metastasis; TRIM29, tripartite motif containing 29.